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Streptococcus pneumoniae is the leading cause of bacterial meningitis. Pneumococcal
meningitis is a life-threatening disease with high rates of mortality and neurological
sequelae. Immune targeting of S. pneumoniae is essential for clearance of infection;
however, within the brain, the induced inflammatory response contributes to
pathogenesis. In this study we investigate the local inflammatory response and the role of
IFN-γ in a murine model of pneumococcal meningitis induced by intracranial injection of
type 4 S. pneumoniae. Lymphoid and myeloid cell populations involved in meningitis, as
well as cytokine gene expression, were investigated after infection. Animals were treated
with a monoclonal antibody specific for murine IFN-γ to evaluate its role in animal survival.
Intracranial inoculation of 3 × 104 colony-forming units of type 4 strain TIGR4 caused
75% of mice to develop meningitis within 4 days. The amount of lymphocytes, NK cells,
neutrophils, monocytes and macrophages in the brain increased 48 h post infection.
IFN-γ mRNA levels were about 240-fold higher in brains of infected mice compared
to controls. Pro-inflammatory cytokines such as IL-1β and TNF-α, and TLR2 were also
upregulated. In vivo treatment with anti-IFN-γ antibody increased survival of infected
mice. This study shows that IFN-γ produced during meningitis by type 4 S. pneumoniae
enhances bacterial pathogenesis exerting a negative effect on the disease outcome.
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INTRODUCTION
Meningitis by Streptococcus pneumoniae (pneumococcus) is one of the most prevalent among
bacterial meningitis and it is characterized by a high fatality and a high risk of neurological sequelae
(Kornelisse et al., 1995; Merkelbach et al., 2000; van de Beek et al., 2002; Bogaert et al., 2004;
Ramakrishnan et al., 2009; Edmond et al., 2010; Kim, 2010; Koedel et al., 2010b; Mook-Kanamori
et al., 2011; Barichello et al., 2015). Neuronal injury is caused by the joint action of the direct
toxicity of bacterial components and the strong inflammatory host response (Nau and Brück, 2002;
Koedel et al., 2010a,b; Barichello et al., 2012). Mouse models of meningitis are used both to dissect
the molecular pathogenesis of the pneumococcal infection of the brain, and to investigate novel
therapeutic approaches (Chiavolini et al., 2004, 2008; Hirst et al., 2004, 2008; Banerjee et al., 2010;
Woehrl et al., 2011; Mook-Kanamori et al., 2012; Tan et al., 2015). Experimental studies, aimed
to develop new adjunctive therapies to be combined with antimicrobial treatment, have recently
identified in vivo inhibition of cytokines as a promising target. During pneumococcal meningitis,
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bacterial components stimulate the release of inflammatory
cytokines such as TNF-α, IL-1β, and IFN-γ (Wellmer et al.,
2001; Zwijnenburg et al., 2003). Although the role of IFN-γ was
extensively studied in viral infections, its role in acute bacterial
infection is not completely understood and needs to be further
investigated. IFN-γ is mainly secreted by natural killer (NK) but
also by natural killer T (NKT) cells and monocytes as part of the
innate immune response, and by CD4 and CD8 T lymphocytes
as effector mechanism once antigen-specific immunity develops
(Schoenborn and Wilson, 2007; Mildner et al., 2008). IFN-
γ is an important mediator of multiple immune pathways
during inflammation (Schroder et al., 2004) and was found in
the cerebrospinal fluid (CSF) of patients with pneumococcal
meningitis, in concentrations significantly higher than in patients
with meningococcal or haemophilus meningitis (Glimåker et al.,
1994; Kornelisse et al., 1997; Coutinho et al., 2013; Grandgirard
et al., 2013).
The first evidence for a key role of IFN-γ in the pathogenesis
of pneumococcal meningitis was obtained using a type 3 strain
of S. pneumoniae in a mouse model of meningitis (Mitchell
et al., 2012). To determine whether the observed role of
IFN-γ is specific for type 3 strains or it is a general trait
of pneumococcal meningitis, we used type 4 strain TIGR4,
which is considered a prototype of all S. pneumoniae strains
(Tettelin et al., 2001). In fact, type 3 differs significantly from
other pneumococci in important biological traits including
major virulence factors such as the polysaccharide capsule and
the surface protein PspC (Sørensen et al., 1990; Janulczyk
et al., 2000; Iannelli et al., 2002; Bentley et al., 2006).
In this work, type 4 strain TIGR4 was used to induce
meningitis in the murine model, to investigate IFN-γ gene
expression, leukocyte recruitment in the brain, IFN-γ producing
cells, and antibody-mediated in vivo neutralization of IFN-γ
activity.
MATERIALS AND METHODS
Mice
Seven-weeks old female C57BL/6J, purchased from Charles
River (Lecco, Italy), were maintained under specific pathogen-
free conditions in the animal facilities at the University
of Siena, and treated according to national guidelines
(Decreto Legislativo 26/2014). All animal studies were
approved by the Ethics Committee “Comitato Etico Locale
dell’Azienda Ospedaliera Universitaria Senese” and the Italian
Ministry of Health (authorization of the 20th September,
2011).
Bacterial Strains, Media, and Growth
Conditions
S. pneumoniae TIGR4 (type 4) was grown in Tryptic Soy Broth
(TSB, Becton Dickinson, Italy) and stored at −80◦C with 10%
glycerol. Solid media were prepared by addition of 1.5% agar and
3% defibrinated horse blood (Liofilchem, Italy) to TSB. Counts
of colony forming units (CFU) were performed on blood-agar
plates at 37◦C with 5% CO2.
Experimental Model of Meningitis and
Sample Collection
For induction of meningitis, mice were anesthetized by
intraperitoneal (i.p.) injection of xylazine hydrochloride
(4mg/Kg of mouse, Bio 98 S.r.l., Italy) and zolazepam tiletamine
(15mg/Kg ofmouse, Virbac S.r.l., Italy). Animals were inoculated
by the intracranial subarachnoidal route, as previously described
(Chiavolini et al., 2004), using a micro-syringe with 27 gauge
needles (Becton Dickinson, USA), inserting the needle between
the hemispheres to a depth of 2–3mm. Ten microliters of
inoculum (3 × 104 CFU/mouse) was injected into the third
ventricle. Sham-infected mice received 10µl of TSB medium.
In some experiments, IFN-γ was neutralized by intracranial
administration of 30µg anti-IFN-γ (clone R4-6A2, Mabtech,
Sweden) or IgG isotype control (clone eBRG1 rat IgG1 isotype
control, eBioscience, USA) mixed with bacterial inoculum, in a
total volume of 30µl/mouse. Disease severity was graded using
end-points on a scale of 0–5, with 0: normal; 1: piloerection and
decreased spontaneous activity; 2: hunched position and loss of
vigilance; 3: turns upright in >5 s when positioned on the back;
4: does not turn upright; 5: moribund. Animals were euthanized
if/when they reached a score of 4. Survival was recorder for 8
days, with a daily evaluation of clinical score and the weight of
individual mice.
Infected mice were transcardially perfused with ice cold PBS
(Sigma-Aldrich, USA). Brains were collected from individual
mice to perform phenotypic and intracellular flow cytometric
analysis, to evaluate cytokine production, gene expression and
bacterial load. To determine bacterial load, infected mice were
aseptically transcardially perfused with ice cold PBS (Sigma-
Aldrich) and half brain/mouse was plated on multilayer plates,
as previously described (Iannelli and Pozzi, 2004). Plates were
incubated for 48 h at 37◦C with 5% CO2.
Flow Cytometric Analysis
Brains were collected in un-supplemented RPMI 1640 (Sigma-
Aldrich) and mashed onto nylon screens (Sefar Italia, Italy).
For characterization of leukocyte populations by flow cytometry,
cell suspension was digested with collagenase (0.5mg/ml, Sigma-
Aldrich) and DNase I (28 IU/ml, Sigma-Aldrich) for 20min at
room temperature with occasional agitation, and then triturated
several times to break up tissue clumps and returned to incubate
at 37◦C for a further 20min. Following enzymatic digestion,
to remove low density dead cells, debris and myelin, cells
were pelleted and resuspended in 7ml of 30% (v/v) Percoll
(Sigma-Aldrich) in PBS-5% (v/v) fetal calf serum (FCS, Life
Technologies, USA) then centrifuged at 1400 × g for 20min at
4◦C. The upper Percoll layers were carefully removed and the
cell pellet resuspended in PBS-5% (v/v) FCS. After washing cells
in PBS-5% (v/v) FCS, contaminating erythrocytes were lysed by
RBC lysis buffer (eBioscience), according with themanufacturer’s
protocol. Cell suspension was labeled with LIVE/DEAD Yellow
Cell Stain Kit (Life Technologies) according to themanufacturer’s
instruction and incubated for 20min at 4◦C. After washes in
PBS, CD16/32mAb (clone 93, eBioscience), diluted 1:100 in
PBS-3% (v/v) FCS, was added in a volume of 25µl/sample for
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20min at 4◦C, followed by incubation with a mix of fluorescent
antibodies in PBS-3% (v/v) FCS in a final volume of 50µl/sample
for others 20min at 4◦C. After staining, cell suspension was
fixed with fixation buffer (Becton Dickinson), according with the
manufacturer’s protocol.
Brain cells for intracellular cytokine assay were prepared
using isolation and staining procedures, as described below. Mice
received an i.p. injection of 250µg brefeldin A ([BFA, Sigma-
Aldrich], 100µl/mouse in saline solution) 6 h before the sacrifice.
Following euthanasia, performed 48 h post infection, brains were
collected into ice cold RPMI 1640 containing 10µg/ml BFA
and disaggregated pressing through nylon screens of 100µm
(Becton Dickinson). Cell suspension was pelleted, resuspended
in 30% Percoll containing BFA and centrifuged at 1400 ×
g for 20min at 4◦C. Contaminating erythrocytes were lysed
as previously described. After extracellular staining performed
as described above, with the addition of BFA to the mix of
antibodies, the BD Cytofix/Cytoperm kit (Becton Dickinson)
was used according with the manufacturer’s protocol for the
intracellular staining. Cellular suspension was stained with:
PE-Cy7 conjugated anti-mouse CD335 (Nkp46, clone 29A1.4,
eBioscience), PerCP-Cy5.5 conjugated anti-mouse Ly6G (Gr-
1, clone RB6-8C5, eBioscience), APC-eFluor 780 conjugated
anti-mouse F4/80 (clone BM8, eBioscience), Alexa Fluor 488
conjugated anti-mouse CD3e (clone 145-2c11, eBioscience), PE-
CF594 conjugated anti-mouse CD11b (clone M1/70, Becton
Dickinson), Horizon V500 conjugated anti-mouse CD45 (clone
30-F11, Becton Dickinson), Brillant Violet conjugated anti-
mouse Ly6C (clone AL-21, Becton Dickinson), Alexa Fluor
700 conjugated anti-mouse CD45R (B220, clone RA3-6B2,
eBioscience), APC conjugated anti-mouse IFN-γ (clone XMG1,2,
eBioscience). Markers were set according to the respective IgG
isotype controls. All samples were acquired on a five-laser LSR
II (Becton Dickinson Biosciences), and data were analyzed using
FlowJo software (Tree Star, USA).
Quantitative RT-PCR
Brain hemispheres were collected in RNA Later (Ambion,
Thermo Fisher, USA) and stored at −80◦C. RNA Later solution
was removed from thawed samples and 40mg of tissue were
homogenized in RA1 lysis buffer (Macherey Nagel, Germany)
using 5mm stainless steel beads (Qiagen, Germany) in Tissue
Lyser (Qiagen). Total RNAwas extracted with a Nucleospin RNA
II isolation kit (Macherey Nagel) following the manufacturer’s
protocol. Integrity and quantification of RNA were evaluated
using the Agilent RNA 6000 Nano Kit (Agilent Technologies,
Italy) on the Agilent 2100 Bioanalyzer (Agilent Technologies).
RNA samples were stored at −80◦C until reverse transcription.
Complementary DNA was obtained from 1µg of total RNA
for each sample using Quantitect Reverse Transcription Kit
(Qiagen). Real Time PCRwas performed to evaluate IFN-γ, TNF-
α, IL-1β, IL-10, TGF-β, TLR2, TLR4, and TLR9 gene expression
by 480 Light Cycler (Roche, Switzerland) using Sybr Green Light
Cycler 480 mix (Roche) with cycling conditions as follows: 5min
95◦C denaturation and then 40 repeats of step amplification cycle
(95◦C for 10 s; 60◦C for 10 s; 72◦C for 10 s). Sequences of the
primers are as follows: IFN-γ, forward, 5′-CAGCAACAGCAAG
GCGAAA-3′, reverse, 5′-GCTGGATTCCGGCAACAG-3′; TNF-
α, forward, 5′-CGTCGTAGCAAACCACCAAGT-3′, reverse, 5′-
CCTTGAAGAGAACCTGGGAGT-3′; IL-1β, forward, 5′-GAT
GAAGGGCTGCTTCCAAAC-3′, reverse, 5′-ATCCCATGAGT
CACAGAGG-3′; IL-10, forward, 5′-GGTTGCCAAGCCTTAT
CGG-3′, reverse, 5′-TCTTCACCTGCTCCACTGCC-3′; TGF-
β1, forward, 5′-CGCAACAACGCCATCTATGAG-3′, reverse,
5′-GTATCAGTGGGGGTCAGCAG-3′; TLR2, forward, 5′-GT
GTCTGGAGTCTGCTGTG-3′, reverse, 5′-GGAGCTTTCTTGG
GCTTC-3′; TLR4, forward, 5′-CAGAGCCGTTGGTGTATC-3′,
reverse, 5′-CCCATTCCAGGTAGGTGT-3′; TLR9, forward, 5′-C
TGCCTTGCTCTGTCTTAC-3′, reverse, 5′-CTGTTCTGTGTG
GGTCTG-3′; RPL13a, forward, 5′-CTTAGGCACTGCTCCTGT
GGGT-3′, reverse, 5′-GGTGCGCTGTCAGCTCTCTAAT-3′.
RPL13a encoding gene was utilized as endogenous gene. The
relative gene expression levels in each sample were normalized
against the brains of uninfected mice using the 11Ct method
(Livak and Schmittgen, 2001).
Statistical Analysis
Survival experiments were analyzed by the Kaplan-Meier
method, using the Log-Rank test. Statistical significance among
two independent groups (i.e., infected and control groups)
was determined by two tailed Mann-Whitney test. Statistical
significance was defined as P ≤ 0.05. Graphpad 4.0 software was
used for analysis.
RESULTS
Analysis of Intracranial Infection by Type 4
S. pneumoniae
Pneumococcal meningitis was induced in inbred C57BL/6J mice
inoculating the wild type S. pneumoniae serotype 4 (TIGR4)
by the intracranial subarachnoidal route as previously described
(Chiavolini et al., 2004). Survival and clinical parameters were
daily evaluated up to 8 days post infection.
In order to identify the minimum amount of bacteria required
for inducing meningitis, groups of 4 mice were infected by the
intracranial route with four scalar doses of TIGR4, between
3 × 103 and 1 × 105 CFU/mouse. The dose of 3 × 104
CFU/mouse killed 50 and 75% of mice 3 and 4 days post
infection, respectively. Similar percentages were observed inmice
infected with 105 CFU/mouse, while both lower doses of 3× 103
and 104 CFU had higher survival percentages (data not shown).
The amount of type 4 S. pneumoniae chosen for intracranial
challenge experiments was 3 × 104 CFU/mouse. Groups of 8
mice were infected with S. pneumoniae TIGR4 or injected with
bacterial growth medium. Three days post infection with TIGR4,
56% of infected mice survived and values decreased until 8 days
post infection (Figure 1A), when about 6% of mice survived.
Median survival time of mice challenged with TIGR4 was 96 h.
On the contrary, all mice of the control group, injected by the
intracranial route with the bacterial growth medium, survived
with no signs of disease. Survival analysis was supported by
daily clinical parameters observation, in terms of weight and
clinical score. A decrease of about 25% of initial weight was
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FIGURE 1 | Murine model of meningitis by S. pneumoniae. C57BL/6J
mice were infected by the intracranial route with 3 × 104 CFU of S.
pneumoniae strain TIGR4 (filled circles) or injected with bacterial growth
medium (control, open circles). Data are from two independent experiments
with 8 mice/group, and animals were monitored up to 8 days post infection.
(A) Kaplan-Meier curve of mouse survival. Results were expressed as
percentage of survival over time, and statistical differences were evaluated
between infected mice and control group using Log-Rank test. Asterisks
indicate statistical significance (***P < 0.0001). (B) Clinical score analysis was
evaluated using a scale for severity of disease, from 0 (normal) to 5 (moribund),
and values were reported as mean value ± SEM.
estimated starting from 3 days post infection (data not shown).
The clinical score of infected mice gradually increased following
infection, while all control mice showed no signs of illness and
no differences in clinical score compared to initial condition
(Figure 1B).
Our data, analysing survival and clinical parameters in a
murine model of intracranial infection with S. pneumoniae
TIGR4, suggested that the dose of 3 × 104 CFU/mouse and the
time point of 48 h from challenge are optimal for the subsequent
characterization of the induced immune reaction since mice
survived but signs of the meningitis were evident.
Gene Expression in Brain of Mice with
Meningitis
Mice challenged with S. pneumoniae TIGR4 were sacrificed
48 h post infection (n = 4–6 mice/group in two independent
experiments). Brains were collected and mRNAs were extracted
in order to evaluate gene expression of cytokines and TLRs
during meningitis (Figure 2). Interestingly, intracranial infection
with 3 × 104 CFU/mouse of TIGR4 induced a significant IFN-γ
gene expression with an increase of about 240-folds compared
to the control group injected with bacterial growth medium
(Figure 2; P < 0.001). Also the gene expression of inflammatory
cytokines such as TNF-α and IL-1β in brains of infected mice
showed a considerable relative increase of about 70- and 140-
folds, respectively, compared to the control group (P < 0.001,
Figure 2). Gene expression of the regulatory cytokine IL-10
increased of about 20-folds (P < 0.001, Figure 2). On the
contrary, no differences between infected and control mice was
observed for TGF-β gene expression at this time point (data
not shown). The analysis of TLR gene expression during S.
pneumoniaemeningitis showed a significant increase of about 10-
folds (P < 0.001) and 3-folds (P < 0.05) for TLR2 and TLR4,
respectively (Figure 2), while no statistically significant increase
was observed for TLR9 (data not shown).
Leukocyte Recruitment and Source of
IFN-γ in Brain of Mice with S. pneumoniae
Meningitis
To characterize pneumococcal meningitis, leukocyte recruitment
was analyzed in brains of mice with meningitis 48 h post
infection with TIGR4 (n = 3–6 mice/group in four independent
experiments) (Figures 3A,B) and the source of IFN-γ was
investigated by flow cytometric analysis (Figure 4). The average
number of leukocytes (CD45+ live cells) detected in mice was
about 6.4 × 104/brain. Neutrophils (CD45hiCD11bhiLy6G+
cells) were the most abundant cell population in the
inflammatory infiltrate detected in TIGR4 infected brains,
representing the 27.4± 6.5% (mean± SEM) of CD45+ cells (P <
0.001 vs. control, Figure 3B). Within the leukocyte population
detected in the brain of TIGR4 infected mice, was also observed a
significant increase of monocytes (CD45hiCD11bhiLy6G−Ly6C+
cells) representing the 20.7 ± 3.1% of CD45+ cells (P < 0.001),
macrophages (CD45hiCD11bhiF4/80+ cells) with the 18.6 ± 4%
(P < 0.001), lymphocytes (CD45hiCD3+ cells) with the 3.9 ±
0.5% (P < 0.001) and NKs (CD45hiCD3−NKp46+ cells) with
the 5 ± 1% (P < 0.001) (Figure 3B). B cells (CD45hiB220+
cells) were also investigated and corresponded to 0.3 ± 0.1%
of leukocytes (data not shown). In the brain of control mice,
injected with bacterial growth medium, only few leukocytes
were observed with 0.4 ± 0.3% of neutrophils, 0.07 ± 0.04%
of monocytes, 0.3 ± 0.1% of macrophages, 0.4 ± 0.15% of
lymphocytes and 0.7± 0.15% of NK cells.
To characterize the IFN-γ involvement during pneumococcal
meningitis, cells expressing IFN-γ were analyzed in the brain by
intracellular staining (Figures 4A,B). Up to 14% of NKs were
positive for IFN-γ staining 48 h post infection. Not surprisingly,
also monocytes, macrophages, and neutrophils produced lower
amounts of IFN-γ (about 3%; Figure 4B). The MFI of NKs
producing IFN-γ was about 10 times higher than the MFI of
the other cell populations analyzed, confirming that NKs are the
main source of IFN-γ in brain of S. pneumoniae TIGR4 infected
mice. No IFN-γ staining was detected in control mice injected
by the intracranial route with bacterial growth medium (data not
shown).
IFN-γ Antibody-Mediated Neutralization
The involvement of IFN-γ produced in the brain during
meningitis with S. pneumoniae TIGR4 was further confirmed by
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FIGURE 2 | Cytokine and TLR gene expression in the mouse brain 48h post infection. The relative IFN-γ, TNF-α, IL-1β, IL-10, TLR2, and TLR4 gene
expression was determined by RT-PCR in brains of C57BL/6J mice infected by the intracranial route with 3 × 104 CFU of S. pneumoniae TIGR4 (filled circles). As
control, a group of mice was injected with bacteria growth medium (open circles). All animals were sacrificed 48 h post infection. Symbols represent individual mice
and bars represent the geometric mean of each group. Data are from two independent experiments with 4–6 mice/group. Statistical analysis was performed on
log-transformed data between infected and control group using the two tailed Mann-Whitney test. Asterisks indicate statistical significance (*P ≤ 0.05; ***P ≤ 0.001).
IFN-γ antibody-mediated neutralization. Anti-IFN-γ antibody
was administered by the intracranial route at the time of
infection and survival was analyzed. As control, a group of mice
was infected with bacteria and administered with the isotype
control. Two independent experiments were performed, each
with 4 mice/group. Two days post infection all mice infected
with TIGR4 and treated with the anti-IFN-γ antibody survived,
whereas only the 33% of animals treated with the isotype
control survived (P = 0.019, Figure 5A). Eighty-three percent
of mice treated with the IFN-γ neutralizing antibody survived
3 and 4 days post infection, while the survival rates of isotype
control treated mice didn’t change, with 33% of survived animals
(Figure 5A). Differences of mice survival between the two groups
were reduced at day 8, where 33% of mice treated with anti-
IFN-γ antibody and 17% of mice in the control group survived,
respectively (data not shown). All infected mice were monitored
for clinical signs (Figure 5B) up to 4 days post infection.
Interestingly, the inoculum of anti-IFN-γ antibody caused minor
clinical symptoms, compared to control group, supporting the
survival data collected at this early time point.
Bacterial load was also estimated in infected brains 48 h
post infection and data demonstrated that the intracranial
administration of anti-IFN-γ antibody didn’t influence the
presence of bacteria compared to isotype control treated mice,
with values of about 108 CFU/brain (Figure 5C).
DISCUSSION
In this work, we demonstrate the key role of IFN-γ in driving
the pathogenesis of meningitis by serotype 4 S. pneumoniae.
In particular, using the murine model of pneumococcal TIGR4
meningitis, we have shown: (i) high expression of IFN-γ in the
brain of infected mice, (ii) recruitment in the brain of IFN-γ-
producing leukocytes, (iii) protection of mice from lethality by
the in vivo IFN-γ antibody-mediated neutralization.
It is known that pneumococcus infection and the host’s
consequent inflammatory reactions are evident causes of clinical
deterioration and neurologic symptoms, but the understanding
of the interaction between bacterial products and the host’s
inflammatory response leading to neuronal damage is still
incomplete (Gerber et al., 2004). IFN-γ is a key factor in brain
during meningitis by S. pneumoniae, it activates the immune
response but it also may enhance the pathology (Schroder
et al., 2004). It regulates chemokines and adhesion molecules
involved in the trafficking of leukocyte to the site of inflammation
(Schroder et al., 2004) and modulates a range of processes
involved in host immunity in response to S. pneumoniae such as
enhancing the function of macrophages and polymorphonuclear
leukocytes and the release of inflammatory mediators (Gil et al.,
2001). It was recently shown that IFN-γ is a major driver of
pathology during pneumococcal meningitis using serotype 3 S.
pneumoniae (Mitchell et al., 2012). The type 3 strain constitutes
a peculiar group among pneumococci and it distinguishes
from other serotypes mainly for the polysaccharide capsule,
not covalently attached to the cell wall (Sørensen et al., 1990;
Bentley et al., 2006), and the surface protein PspC (Janulczyk
et al., 2000; Iannelli et al., 2002). Here, we characterized the
role of IFN-γ in acute meningitis induced by serotype 4 S.
pneumoniae. To this aim we have adopted the murine model of
pneumococcal meningitis, based on the inoculation of bacteria
into the subarachnoid space (Chiavolini et al., 2004) and we
have adapted it to C57BL/6 mice. This method assures the
development of the pathology and may be particularly useful
to investigate host-pathogen interactions and to develop novel
therapeutic approaches.
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FIGURE 3 | Leukocytes in the brain 48h post infection. The recruitment of leukocytes was quantified by multiparametric flow cytometric analysis in the brains of
C57BL/6J mice collected 48 h post intracranial infection with 3 × 104 CFU of S. pneumoniae TIGR4. As control, a group of mice was injected with bacterial growth
medium. (A) Gating strategy adopted for the identification of leukocyte populations in brain of mice. Lymphocytes (CD45hiCD3+), NKs cells (CD45hiCD3−NKp46+),
neutrophils (CD45hiCD11bhiLy6G+), monocytes (CD45hiCD11bhiLy6G−Ly6C+), and macrophages (CD45hiCD11bhiF4/80+) were detected. (B) Percentages (%) of
cell populations detected in brain of mice infected with S. pneumoniae TIGR4 or injected with bacterial growth medium. Infection with TIGR4 induced the entry in the
brain of about 4% lymphocytes, 5% NK cells, 27% neutrophils, 21% monocytes, and 19% macrophages, all evaluated on CD45+ cells. In control group all cell
populations detected were ≤0.7% of CD45+ cells. Data are from four independent experiments with 3–6 animals/group. Bars represent mean ± SEM. Two tailed
Mann-Whitney test was used for comparison between infected and control group and asterisks indicate statistical significance (***P < 0.001).
The considerable involvement of IFN-γ during meningitis by
TIGR4 S. pneumoniaewas demonstrated by the robust increase of
about 240-folds of mRNA gene expression in brains of infected
mice compared to uninfected animals. This is in line with data
reported in meningitis induced by the serotype 3 S. pneumoniae
(Mitchell et al., 2012). In our work, the role of IFN-γ in
driving the pathology during type 4 S. pneumoniae meningitis
was further confirmed in vivo by the IFN-γ antibody-mediated
neutralization. The survival rate was significantly higher at early
time points after challenge in mice treated with the IFN-γ
blocking antibody compared to the animals treated with the
isotype control. These data were supported also by the reduction
of clinical score values. Interestingly, IFN-γ neutralization did
not significantly affect the amount of bacteria and leukocytes in
brains.
The intracranial infection with TIGR4 induced the
recruitment of different leukocyte populations in the brain with
a high aﬄux of myeloid cells, mainly neutrophils, monocytes
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FIGURE 4 | Cellular source of IFN-γ in the infected brain. Lymphocytes (CD45hiCD3+), NKs (CD45hiCD3−NKp46+), neutrophils (CD45hiCD11bhiLy6G+),
monocytes (CD45hiCD11bhi Ly6G−Ly6C+), and macrophages (CD45hiCD11bhiF4/80+) were analyzed for IFN-γ intracellular staining. Flow cytometric analysis was
performed in brain of mice 48 h post intracranial infection with 3 × 104 CFU of S. pneumoniae TIGR4. (A) Representative flow cytometry dot plot graphs showing the
percentage of IFN-γ+ cells among different cell populations in the brain. The gate for IFN-γ+ cells was set using an appropriate APC-conjugated isotype control.
(B) Symbols represent individual mice and bars represent the mean. Mean values for each cell population were 0.6 ± 0.1% for lymphocytes, 7 ± 2.4% for NK cells,
1.8 ± 0.4% for neutrophils, 3.4 ± 0.8% for monocytes, and 3 ± 0.9% for macrophages.
and macrophages, and also the involvement of small amounts
of lymphocytes and NK cells. The pivotal role of neutrophils
in acute bacterial meningitis has been previously described
(Mildner et al., 2008; Mook-Kanamori et al., 2011). NK cells
were previously indicated as the dominant source of IFN-γ
in meningitis induced by the type 3 S. pneumoniae and their
role in IFN-γ production was confirmed by experiments in
which the depletion of NK cells greatly reduced the amount of
IFN-γ in terms of both protein and mRNA within the brain
(Mitchell et al., 2012). Our data indicated that also 48 h after
intracranial infection with the serotype 4 TIGR4, IFN-γ is
produced mainly by NKs recruited in brain. Not surprisingly,
also monocytes, macrophages, and neutrophils were found
to produce IFN-γ, in line with previous in vitro and in vivo
studies (Munder et al., 1998; Olliver et al., 2011; Gomez et al.,
2015).
We have also demonstrated the production of other
inflammatory cytokines in the brain duringmeningitis by TIGR4,
as indicated by the TNF-α and IL-1β relative gene expression
increase. TNF-α and IL-1β were previously demonstrated
to be involved in hippocampal damage in animal models
(Bogdan et al., 1997; Leib et al., 2001). These inflammatory
cytokines were also detected in CSF of pneumococcal meningitis
patients with a fatal outcome (Ohga et al., 1994; Grandgirard
et al., 2013), triggering damages at brain level and inducing
a negative effect on the disease outcome (Nau and Brück,
2002).
Our data demonstrate the role of IFN-γ in the pathogenesis
of meningitis induced by the type 4 S. pneumonia and further
support that the down-modulation of inflammatory cytokines,
mainly IFN-γ, can be considered a valid strategy for new
adjunctive therapies. Optimal level of cytokines necessary to
not exacerbate the host immune response and also eliminate
the pathogen still needs to be deeply investigated with in vivo
studies (Lee et al., 2007; van de Beek et al., 2012; Barichello et al.,
2015).
Besides proinflammatory cytokines, our study showed that
also the regulatory cytokine IL-10 gene expression increased
in brain of infected mice, while no differences were observed
for TGF-β. TLRs, highly involved in the initial sensing of
pneumococci in the central nervous system, were analyzed
by mRNA gene expression during serotype 4 S. pneumoniae
meningitis and results showed a significant increase mainly
for TLR2, but not for TLR9. The important involvement of
TLR2 in pneumococcal meningitis was previously demonstrated
in TLR2-deficient mice infected with S. pneumoniae serotype
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FIGURE 5 | IFN-γ specific monoclonal antibody treatment. Mice were infected by the intracranial route with 3 × 104 CFU of S. pneumoniae TIGR4 and
administered with a neutralizing anti-IFN-γ antibody (black) or with an isotype control antibody (white) at the time of the bacteria inoculum. To analyze the role of IFN-γ
in pneumococcal meningitis, animals were monitored up to 4 days post infection. Data are from two independent experiments with 4 mice/group. (A) Kaplan-Meier
curve of mouse survival. Results were expressed as percentage of survival over time. (B) Clinical score was evaluated using a scale for severity of disease, from 0
(normal) to 5 (moribund), and reported as mean value ± SEM. (C) Bacterial load estimation in brain of mice 48 h post infection. Mean values ± SEM are reported.
3, showing an increase in the bacterial load and blood-brain
barrier disruption (Echchannaoui et al., 2002; Koedel et al.,
2003).
In conclusion, in this work we show that IFN-γ, highly
expressed by different leukocyte populations in the brain of
TIGR4 infected mice, enhances the development of brain
injury in bacterial meningitis by serotype 4 S. pneumoniae.
Our data highlight the negative effect of IFN-γ on the
disease outcome in the murine model of type 4 pneumococcal
meningitis, and its possible role as critical target in adjunctive
therapies.
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